Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Miki Horiguchi, Ph.D.

Concepts (78)

Back to Profile
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Miki Horiguchi's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Miki Horiguchi has written about over time.
Paclitaxel, 1 publications between 2017 and 2017, average publication date August 2017. Urologic Neoplasms, 1 publications between 2017 and 2017, average publication date August 2017. Statistics as Topic, 1 publications between 2018 and 2018, average publication date April 2018. Clinical Trials as Topic, 1 publications between 2018 and 2018, average publication date September 2018. Kaplan-Meier Estimate, 2 publications between 2018 and 2020, average publication date July 2019. Research Design, 3 publications between 2018 and 2020, average publication date October 2019. Randomized Controlled Trials as Topic, 4 publications between 2018 and 2020, average publication date October 2019. Skin Neoplasms, 2 publications between 2018 and 2023, average publication date July 2020. Proportional Hazards Models, 6 publications between 2018 and 2023, average publication date September 2020. Clinical Trials, Phase III as Topic, 1 publications between 2020 and 2020, average publication date September 2020. Survival Rate, 6 publications between 2018 and 2023, average publication date September 2020. Medical Oncology, 3 publications between 2018 and 2023, average publication date October 2020. Survival Analysis, 4 publications between 2018 and 2023, average publication date April 2021. Colorectal Neoplasms, Hereditary Nonpolyposis, 4 publications between 2020 and 2023, average publication date March 2022. DNA Mismatch Repair, 4 publications between 2020 and 2023, average publication date March 2022. Germ-Line Mutation, 4 publications between 2020 and 2023, average publication date March 2022. Immunotherapy, 2 publications between 2023 and 2023, average publication date January 2023. Neoplastic Syndromes, Hereditary, 1 publications between 2023 and 2023, average publication date August 2023.

To see the data from this visualization as text, click here.
Horiguchi's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (78)
Explore
_
Co-Authors (17)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.